GlassScriptPhysician profile
Phillip Rozak
NPI 1255776019
$2,582.78
in general payments reported to CMS, 2019-2025
12 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $1,666 · 2021: $53.68 · 2022: $39.64 · 2023: $99.88 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $1,595.37 | 2020 | |
| Kci USA, INC. | $216.16 | 2019 | |
| Integra Lifesciences Corporation | $190.77 | 2019 | |
| Kerecis Limited | $148.51 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Endo Pharmaceuticals INC. | $113.66 | 2019-2023 | Xiaflex |
| Axogen | $87.82 | 2019 | |
| Allergan, INC. | $80.65 | 2020-2022 | |
| Smith+Nephew, INC. | $50.61 | 2021-2022 | |
| Sientra, INC. | $32.87 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $27.27 | 2025 | |
| Checkpoint Surgical, INC | $19.96 | 2019 | |
| Ethicon US, LLC | $19.13 | 2025 | Echelon Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Rozak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.